A practical reference on anti-doping testing: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-07-22 and is reviewed periodically as new material appears.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Visual inspection is not sufficient for identity. |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water. |
| Typical storage | -20 °C, desiccated, dark | Protect from repeated temperature changes. |
| Common analytical method | LC-MS or HPLC-UV | Reference standard required for comparison. |
| Common synonyms | SR9009; Stenabolic; REV-ERB agonist | Vendor naming may vary. |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
South Africa blamed SWAPO for instigating the strike and subsequent unrest. While acknowledging that a significant percentage of the strikers were SWAPO members and supporters, the party's acting president Nathaniel Maxuilili noted that reform of South West African labour laws had been a longstanding aspiration of the Ovambo workforce, and suggested the strike had been organised shortly after the crucial ICJ ruling because they hoped to take advantage of its publicity to draw greater attention to their grievances. The strike also had a politicising effect on much of the Ovambo population, as the workers involved later turned to wider political activity and joined SWAPO. Around 20,000 strikers did not return to work but fled to other countries, mostly Zambia, where some were recruited as guerrillas by PLAN. Support for PLAN also increased among the rural Ovamboland peasantry, who were for the most part sympathetic with the strikers and resentful of their traditional chiefs' active collaboration with the police. The following year, South Africa transferred self-governing authority to Chief Fillemon Elifas Shuumbwa and the Ovambo legislature, effectively granting Ovamboland a limited form of home rule. Voter turnout at the legislative elections was exceedingly poor, due in part to antipathy towards the local Ovamboland government and a SWAPO boycott of the polls.
microvillus A small, slender, tubular cytoplasmic projection, generally 0.2–4 micrometres long and 0.1 micrometres in diameter, protruding from the surface of some animal cells and supported by a central core of microfilaments. When present in large numbers, such as on epithelial cells lining the respiratory and alimentary tracts, they form a dense brush border which presumably serves to increase each cell's absorptive surface area.
In January 2011, Parliament passed a law that enforces "strict quality control on universities and introduces tough rules for funding evaluation and peer review". Romania was ranked 49th in the Global Innovation Index in 2025. The nuclear physics facility of the EU's proposed Extreme Light Infrastructure (ELI) laser will be built in Romania. In early 2012, Romania launched its first satellite from the Centre Spatial Guyanais in French Guiana. Starting in December 2014, Romania became a co-owner of the International Space Station.
=== Reducing huntingtin production === Gene silencing aims to reduce the production of the mutant protein, since HD is caused by a single dominant gene encoding a toxic protein. Gene silencing experiments in mouse models have shown that when the expression of mHtt is reduced, symptoms improve. The safety of RNA interference and allele-specific oligonucleotide (ASO) methods of gene silencing have been demonstrated in mice and macaques. Allele-specific silencing approaches attempt to target mHTT while leaving wild-type HTT untouched by leveraging polymorphisms present on only the mutant allele. The first gene silencing trial in humans with HD began in 2015, testing the safety of IONIS-HTTRx, produced by Ionis Pharmaceuticals and led by UCL Institute of Neurology. Mutant huntingtin was detected and quantified for the first time in cerebrospinal fluid from HD mutation-carriers in 2015 using a novel "single-molecule counting" immunoassay, providing a direct way to assess whether huntingtin-lowering treatments are achieving the desired effect. A phase 3 trial of this compound, renamed tominersen and sponsored by Roche Pharmaceuticals, began in 2019 but was halted in 2021 after the safety monitoring board concluded that the risk-benefit balance was unfavourable. A huntingtin-lowering gene therapy trial run by Dutch pharmaceutical company uniQure Biopharma began in 2019, and several trials of orally administered huntingtin-lowering splicing modulator compounds have been announced; of these, votoplam is through Phase 2 trial in 2025.
Sources: en.wikipedia.org
Like many other sea anemones, S. helianthus excretes a variety of toxins that can serve different purposes such as prey capture, protection and defense against predators. In specific, Sticholysin II (St II) is a cytolysin that has been extracted from the nematocysts of Sun Anemones and further examined by method of immunoperoxidase staining (structure included- Pennington et al.). Basulto et al. concludes that Sticholysin II functions in exclusive roles within the anemone's physiology, including predation and digestion. Another study revealed a similar lysin, known as Sticholysin I (St I), suggesting multiple isoforms of the same lysin. These two Sticholysins are further expanded on by Alvarez et al., whereas they are described as “pore-forming toxins”. S. helianthus are also capable of producing polypeptide neurotoxins. Kem et al. reports a study where a newly found variant of actiniid neurotoxin, namely Sh 1, was extracted from S. helianthus and yielded genetic similarity to toxin II of Heteractic paumotensis., another species in family Stichodactylidae.
On 6 April 2019, it was announced at a press conference that Rieflin would take another break from King Crimson to attend to family matters; his place on keyboards for the 2019 50th anniversary tour was set to be taken by Theo Travis of Soft Machine, an occasional duo collaborator with Fripp. Although Travis joined the band for rehearsals, Fripp said on 2 May that the band had decided that it was no longer possible to have other musicians deputising for Rieflin and for this reason would "proceed as a Seven-Headed Beast" without Travis. Rieflin's parts were divided among Fripp, Stacey, Jakszyk, Collins, and Levin. On 11 June, King Crimson's entire discography was made available on streaming services, as part of the band's 50th anniversary celebration. On 24 March 2020, Rieflin died of cancer. In the same year, King Crimson collaborator Keith Tippett died after several years of illness on 14 June, and former bassist and singer Gordon Haskell died from lung cancer on 15 October. King Crimson toured North America and then Japan in 2021. Recordings from dates on the American leg of the tour were released as the "official bootleg" live album Music Is Our Friend: Live in Washington and Albany, featuring music from across the band's lifetime plus two new Tony Levin cadenzas.
=== Certification === Several bodies independently certify the production of tea, such as Rainforest Alliance, Fairtrade, UTZ Certified, and Organic. From 2008 to 2016, sustainability standards-certified tea production experienced a compound annual growth rate of about 35%, accounting for at least 19% of overall tea production. In 2016, at least 1.15 million tonnes of sustainably certified tea was produced, valued at US$2 billion. Rainforest Alliance certified tea is sold by Unilever brands Lipton and PG Tips in Western Europe, Australia and the U.S. Fairtrade certified tea is sold by a large number of suppliers around the world. UTZ Certified tea is sold by Pickwick tea.
Sources: en.wikipedia.org
=== Art history === In European pre-historic societies, sculptures of female figures with pronounced or highly exaggerated breasts were common. A typical example is the so-called Venus of Willendorf, one of many Paleolithic Venus figurines with ample hips and bosom. Artifacts such as bowls, rock carvings and sacred statues with breasts have been recorded from 15,000 BC up to late antiquity all across Europe, North Africa and the Middle East. Many female deities representing love and fertility were associated with breasts and breast milk. Figures of the Phoenician goddess Astarte were represented as pillars studded with breasts. Isis, an Egyptian goddess who represented, among many other things, ideal motherhood, was often portrayed as suckling pharaohs, thereby confirming their divine status as rulers. Even certain male deities representing regeneration and fertility were occasionally depicted with breast-like appendices, such as the river god Hapy who was considered to be responsible for the annual overflowing of the Nile.
=== Manufactured products === Environmentally beneficial, low-cost substitutes for rigid thermoplastic and fired ceramic are made using sCO2 as a chemical reagent. The sCO2 in these processes is reacted with the alkaline components of fully hardened hydraulic cement or gypsum plaster to form various carbonates. The primary byproduct is water. sCO2 is used in the foaming of polymers. Supercritical carbon dioxide can saturate the polymer with solvent. Upon depressurization and heating, the carbon dioxide rapidly expands, causing voids within the polymer matrix, i.e., creating a foam. Research is ongoing on microcellular foams. An electrochemical carboxylation of a para-isobutylbenzyl chloride to ibuprofen is promoted under sCO2.
==== Breast cancer ==== In combination with low doses of herceptin, selective ADAM10 inhibitors decrease proliferation in HER2 over-expressing cell lines while inhibitors, that do not inhibit ADAM10, have no impact. These results are consistent with ADAM10 being a major determinant of HER2 shedding, the inhibition of which, may provide a novel therapeutic approach for treating breast cancer and a variety of other cancers with active HER2 signaling. The presence of the product of this gene in neuronal synapses in conjunction with protein AP2 has been seen in increased amounts in the hippocampal neurons of Alzheimer's disease patients.
SIMS and FAB are quite similar. SIMS uses an ion beam, usually Ar+ or Cs+. FAB uses a neutral atom beam, usually Ar or Xe. For SIMS and FAB, if the matrix compound is more acidic than the analyte, then predominantly (M + H)+ forms formed, and conversely (M − H)−. Also possibly forming (M + Na)+, (M + K)+, etc, if the matrix is contaminated incidentally (adventitiously) by sodium, potassium, etc. Typical matrix materials include glycerol, thioglycerol, 3-nitrobenzyl alcohol, diethanolamine, triethanolamine, and dithiothreitol-dithioerythritol mixture. They are usually used to analyze polypeptides and oligonucleotides up to 20 kDa. MALDE uses a photon beam, usually the soft-UV 337 nm nitrogen laser. It can also use an infrared (IR) laser for direct analysis of samples contained in gels or thin-layer chromatography (TLC) plates. MALDE can analyze small polymers (~1 kDa), to oligosaccharides, oligonucleotides and polypeptides, antibodies, up to small proteins (~300 kDa). It is highly sensitive, requiring only femtomoles of sample. Desorption/ionization on silicon (DIOS) is similar to MALDE, but without the matrix. The sample is deposited directly on a nanostructured (porous silicon) surface and the sample desorbed directly from the nanostructured surface through the adsorption of laser light energy. DIOS has been used to analyze organic molecules, metabolites, biomolecules and peptides, and, ultimately, to image tissues and cells.
Sources: en.wikipedia.org
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.
The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.
Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.